Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Ketone bodies as a therapeutic for Alzheimer's disease.

Henderson ST.

Neurotherapeutics. 2008 Jul;5(3):470-80. doi: 10.1016/j.nurt.2008.05.004. Review.

2.

Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function.

Hertz L, Chen Y, Waagepetersen HS.

J Neurochem. 2015 Jul;134(1):7-20. doi: 10.1111/jnc.13107. Epub 2015 Apr 23. Review.

3.

Hypometabolism as a therapeutic target in Alzheimer's disease.

Costantini LC, Barr LJ, Vogel JL, Henderson ST.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S16. doi: 10.1186/1471-2202-9-S2-S16. Review.

4.

Regulation of glucose and ketone-body metabolism in brain of anaesthetized rats.

Ruderman NB, Ross PS, Berger M, Goodman MN.

Biochem J. 1974 Jan;138(1):1-10.

5.

Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.

VanItallie TB.

Metabolism. 2015 Mar;64(3 Suppl 1):S51-7. doi: 10.1016/j.metabol.2014.10.033. Epub 2014 Oct 30. Review.

PMID:
25468143
6.

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease.

Newport MT, VanItallie TB, Kashiwaya Y, King MT, Veech RL.

Alzheimers Dement. 2015 Jan;11(1):99-103. doi: 10.1016/j.jalz.2014.01.006. Epub 2014 Oct 7.

7.

Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention.

Ding F, Yao J, Rettberg JR, Chen S, Brinton RD.

PLoS One. 2013 Nov 11;8(11):e79977. doi: 10.1371/journal.pone.0079977. eCollection 2013.

8.

Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.

Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S.

Neurobiol Aging. 2004 Mar;25(3):311-4.

PMID:
15123336
9.

Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester.

Hashim SA, VanItallie TB.

J Lipid Res. 2014 Sep;55(9):1818-26. doi: 10.1194/jlr.R046599. Epub 2014 Mar 5. Review.

10.

Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease.

Cunnane SC, Courchesne-Loyer A, St-Pierre V, Vandenberghe C, Pierotti T, Fortier M, Croteau E, Castellano CA.

Ann N Y Acad Sci. 2016 Mar;1367(1):12-20. doi: 10.1111/nyas.12999. Epub 2016 Jan 14.

PMID:
26766547
11.

Brain uptake and metabolism of ketone bodies in animal models.

Nehlig A.

Prostaglandins Leukot Essent Fatty Acids. 2004 Mar;70(3):265-75. Review.

PMID:
14769485
12.

Contribution of brain glucose and ketone bodies to oxidative metabolism.

Zhang Y, Kuang Y, LaManna JC, Puchowicz MA.

Adv Exp Med Biol. 2013;765:365-70. doi: 10.1007/978-1-4614-4989-8_51.

PMID:
22879057
13.

A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.

Heininger K.

Rev Neurosci. 2000;11 Spec No:213-328. Review.

PMID:
11065271
14.

2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.

Yao J, Chen S, Mao Z, Cadenas E, Brinton RD.

PLoS One. 2011;6(7):e21788. doi: 10.1371/journal.pone.0021788. Epub 2011 Jul 1.

15.

Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.

Castellano CA, Nugent S, Paquet N, Tremblay S, Bocti C, Lacombe G, Imbeault H, Turcotte É, Fulop T, Cunnane SC.

J Alzheimers Dis. 2015;43(4):1343-53. doi: 10.3233/JAD-141074.

PMID:
25147107
16.

Medical aspects of ketone body metabolism.

Mitchell GA, Kassovska-Bratinova S, Boukaftane Y, Robert MF, Wang SP, Ashmarina L, Lambert M, Lapierre P, Potier E.

Clin Invest Med. 1995 Jun;18(3):193-216. Review.

PMID:
7554586
17.

PET study of 11C-acetoacetate kinetics in rat brain during dietary treatments affecting ketosis.

Bentourkia M, Tremblay S, Pifferi F, Rousseau J, Lecomte R, Cunnane S.

Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E796-801. doi: 10.1152/ajpendo.90644.2008. Epub 2009 Jan 27.

18.

Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's Disease.

Cunnane SC, Courchesne-Loyer A, Vandenberghe C, St-Pierre V, Fortier M, Hennebelle M, Croteau E, Bocti C, Fulop T, Castellano CA.

Front Mol Neurosci. 2016 Jul 8;9:53. doi: 10.3389/fnmol.2016.00053. eCollection 2016.

19.

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.

Chen Z, Zhong C.

Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11. Review.

20.

Using positron emission tomography to study human ketone body metabolism: a review.

Bouteldja N, Andersen LT, Møller N, Gormsen LC.

Metabolism. 2014 Nov;63(11):1375-84. doi: 10.1016/j.metabol.2014.08.001. Epub 2014 Aug 7. Review.

PMID:
25195069

Supplemental Content

Support Center